深圳市亚辉龙生物科技股份有限公司关于控股股东、实际控制人兼董事长及其一致行动人权益变动触及1%整数倍的提示性公告

Group 1 - The core point of the announcement is that the controlling shareholder, actual controller, and chairman of Shenzhen Yahui Long Biotechnology Co., Ltd., Mr. Hu Kunhui, has reduced his shareholding by 11,408,536 shares through block trading, decreasing his and his concerted parties' total shareholding from 49.06% to 47.06%, which triggers a 1% change in equity [2][3]. - The reduction in shareholding is part of a previously disclosed plan and does not trigger a mandatory tender offer, nor does it change the company's controlling shareholder or actual controller, ensuring no significant impact on the company's governance structure or ongoing operations [2][3]. - As of the date of the announcement, the reduction plan has not been fully implemented, and the information disclosure obligor will comply with legal and regulatory requirements for the reduction and will fulfill information disclosure obligations in a timely manner [3]. Group 2 - The announcement confirms that the information provided by the controlling shareholder and concerted parties is true, accurate, and complete, with no false records or misleading statements [1]. - The company’s board of directors guarantees that the content of the announcement is consistent with the information provided by the information disclosure obligor [1]. - The specific details of the share reduction plan were previously disclosed on August 19, 2025, on the Shanghai Stock Exchange website [2].